OPDIVO® (nivolumab) OPDIVO ® (nivolumab) is a prescription medicine used in combination with YERVOY ® (ipilimumab) to treat adults with a type of liver cancer called hepatocellular carcinoma (HCC) when your liver cancer cannot be removed by surgery or has spread, and you have received prior treatment with sorafenib
Frequently Asked Questions (FAQ) | OPDIVO® (nivolumab) Find answers to frequently asked questions about OPDIVO® (nivolumab) including what OPDIVO® is, how immunotherapy works, and what are the side effects of OPDIVO®
Subcutaneous Injection Immunotherapy Treatment| OPDIVO Qvantig . . . Learn more about OPDIVO Qvantig™ (nivolumab+hyaluronidase-nvhy) as a subcutaneous injection immunotherapy treatment option for your fight against cancer Please see Indication and Important Safety Information
OPDIVO® Support Patient Resources | OPDIVO® (nivolumab) Whether you're a new or continuing OPDIVO® (nivolumab) patient, find resources that can support you through a cancer diagnosis and during treatment Access helpful resources and find assistance for OPDIVO® patients here
Patient and Caregiver Stories | OPDIVO® (nivolumab) Watch videos of real OPDIVO® (nivolumab) patients and caregivers Learn more about patients' diagnoses and treatment experiences Please see Indication and Important Safety Information
Financial Information: Cost, Access Affordability - OPDIVO Important Facts About OPDIVO® (nivolumab) and OPDIVO + YERVOY® (ipilimumab) This is a summary of important information that you need to know about OPDIVO and OPDIVO + YERVOY Your healthcare team can work with you to help answer any questions you may have about these medications